FNYS
AMAG

First New York Securities’s AMAG Pharmaceuticals AMAG Stock Holding History

First New York Securities’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-6,316
Closed -$122K – 397
2014
Q1 		$122K Buy
+6,316
New +$134K 0.06% 198

Other funds holding AMAG

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

First New York Securities's AMAG Position: Q2 2014 in Review

First New York Securities sold out of AMAG Pharmaceuticals (AMAG) in Q2 2014, closing a stake of 6,316 shares — an estimated $122K sold.

First New York Securities first reported a position in AMAG in Q1 2014 and held it in 1 quarter. The position peaked at $122K in Q1 2014. 100 funds tracked by Wall St. Rank hold AMAG as of Q2 2014.

  • First New York Securities reported no remaining AMAG Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • First New York Securities sold 6,316 AMAG Pharmaceuticals shares in Q2 2014, an estimated $122K.
  • First New York Securities first reported a position in AMAG Pharmaceuticals in Q1 2014 and held it in 1 quarter.
  • First New York Securities's AMAG Pharmaceuticals position peaked at $122K in Q1 2014.
  • 100 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2014.

Based on First New York Securities's 13F filing for Q2 2014, filed 15 Aug 2014.